Tuesday, 31 March 2020

Japan News

  • Fujikura to license Cellmid's cancer antibody

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: Japan-based Fujikura Kasei is going to licence cancer diagnostic antibody midkine (MK) developed by Australia's Cellmid at a payment of around $440 million. Under the terms of th...Read more

  • Molecular diagnostics is key to future

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    China, Japan, India and Singapore are leveraging on genetic technologies to develop molecular diagnostic platform which is much more efficient and effective in tracking diseases. According ...Read more

  • GE Healthcare, Osaka University join hands

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2013

    Singapore: GE Healthcare Life Sciences has tied up with Osaka University to allow students to have access to GE Healthcare's expertise in training and technologies for biopharmaceutical res...Read more

  • OHK & Mitsubishi to launch HemaClear in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2013

    Singapore: OHK Medical Devices, manufacturer of the HemaClear, single-use, sterile exsanguinating tourniquet device, announced that it has entered an exclusive agreement with Japan Medicaln...Read more

  • Neuland Labs strengthens commitment to Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Hyderabad: Neuland Laboratories entered into a manufacturing collaboration with Tokyo-based API named Apic, which is a healthcare unit of Mitsubishi Chemical Holdings Group that produces A...Read more

  • Affymax, Takeda announce J-code for Omontys

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2013

    Singapore: Affymax and Takeda Pharmaceuticals, US, announced that the J-code assigned by the Centers for Medicare and Medicaid Services (CMS) for Omontys (peginesatide) injection is now ef...Read more

  • Now Eisai joins global health fund

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

    Singapore: Japan-based Eisai co-established the Global Health Innovative Technology Fund (GHIT Fund) to advance the R&D of new medicines, vaccines, and diagnostics from Japan to fight i...Read more

  • Astellas, Ambit Biosciences begin quizartinib trial

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Singapore: Japan-headquartered Astellas Pharma and Ambit Biosciences have initiated the phase IIb open-label clinical trial of quizartinib as monotherapy in patients with relapsed and refra...Read more

  • Teva enters Korean pharmaceutical market

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

    Singapore: Israel-based Teva Pharmaceutical and Korea's Handok Pharmaceuticals will establish a business venture in South Korea, allowing Teva to gain entrance into the Korean pharmaceutica...Read more

  • DHL expands secure cold chain network

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Apr, 2013

    Singapore: DHL Global Forwarding, the air and ocean freight specialist, has expanded its Qualified Envirotainer Provider (QEP) Accreditation to 30 stations in locations at Germany, France, ...Read more

  • US FDA to grant priority review to Eisai's AcipHex

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

    Singapore: The US Food and Drug Administration (FDA) has accepted for review Eisai's new drug application (NDA) for a new sprinkle capsule formulation (5mg and 10mg) of the proton-pump inhi...Read more

  • Given Imaging's Colon PillCam cleared in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

    Singapore: Israel-based Given Imaging, a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, announced that PillCam Colon has been cleared by Japan's Pharmace...Read more

  • CPhI Japan wins prestigious AEO Excellence Award

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2012

    Singapore: CPhI Japan won the Organiser Team of the Year award at the Association of Event Organisers (AEO) Excellence Awards. CPhI Japan is a collaboration of UBM Asia in Japan and UBM Liv...Read more

  • FDA approval for Daiichi Sankyo packaging facility

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2012

    Singapore: Daiichi Sankyo has received US Food and Drug Administration (FDA) approval to package products at its first US-based packaging facility in Bethlehem, PA. With this approval, the ...Read more

  • Japan to consider new legislation to regulate clinical studies

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Japan is considering new legislation to regulate clinical studies in the country, according to a report published in The Japan News. The move follows recent revelations of data ...Read more

  • Astellas Pharma launches new vaccine in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2012

    Singapore: Astellas Pharma has launched the combined vaccine for the prevention of pertussis, diphtheria, tetanus, and poliomyelitis (Quattrovac subcutaneous injection syringe), which is ma...Read more

  • Shimadzu launches gas chromatograph mass spectrometer

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2012

    Singapore: Shimadzu Corporation introduced the GCMS-TQ8030 ultra fast triple quadrupole gas chromatograph mass spectrometer, achieving the next step forward in Shimadzu's GC-MS history of i...Read more

  • Eisai pharma opens its new Australia division

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Nov, 2014

    Singapore: Eisai, a Japanese pharmaceutical company, is seeking to expand its global network by opening a new office in Australia. The new outlet will serve as a platform to market Eisai's ...Read more